Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

Peking Union Medical College Hospital, Beijing

Fujian Medical University Union Hospital, Fuzhou

Harbin medical university affiliated tumor hospital, Harbin

The First Affiliated Hospital of Xinxiang Medical College, Xinxiang

Henan Cancer Hospital, Zhengzhou

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Hubei Cancer Hospital, Wuhan

Hunan Cancer Hospital, Changsha

The Second Xiangya Hospital of Central South University, Changsha

Jiangsu Cancer Hospital, Nanjing

The First Affiliated Hospital of Nanjing Medical University, Nanjing

Shandong Cancer Hospital, Jinan

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai

Shanghai Chest Hospital, Shanghai

The First Affiliated Hospital of Xian Jiaotong University, Xian

Tianjin Medical University Cancer Hospital, Tianjin

Cancer Hospital of Xinjiang Medical University, Ürümqi